维普中文期刊产品整合服务

Multifunctional polymeric micelle-based chemo-immunotherapy with immune checkpoint blockade for efficient treatment of orthotopic and metastatic breast cancer

查看全文 作  者:Jiaojie [1]Wei;Yang [1]Long;Rong [1]Guo;Xinlei [1]Liu;Xian [1]Tang;Jingdong [1]Rao;Sheng [1]Yin;Zhirong [1]Zhang;Man [1]Li;Qin [1]He 高影响力作者 机构地区:[1]Key Laboratory of Drug Targeting and Drug Delivery Systems, West China School of Pharmacy, Sichuan University高影响力机构 出  处:《Acta Pharmaceutica Sinica B》索引2019年第9卷第4期,共13页高影响力期刊 基  金:funded by the Major Projects of the National Natural Science Foundation of China(81690261);the National Natural Science Foundation of China(81703450);the Postdoctoral Research Foundation of China(2017M620429) 摘  要:Immunotherapy has become a highly promising paradigm for cancer treatment. Herein, a chemo-immunotherapy was developed by encapsulating chemotherapeutic drug doxorubicin(DOX) and Toll-like receptor 7 agonist imiquimod(IMQ) in low molecular weight heparin(LMWH)-D-α-tocopheryl succinate(TOS) micelles(LT). In this process, LMWH and TOS were conjugated by ester bond and they were not only served as the hydrophilic and hydrophobic segments of the carrier, but also exhibited strong anti-metastasis effect. The direct killing of tumor cells mediated by DOX-loaded micelles(LT-DOX)generated tumor-associated antigens, initiating tumor-specific immune responses in combination with IMQ-loaded micelles(LT-IMQ). Furthermore, the blockade of immune checkpoint with programmed cell death ligand 1(PD-L1) antibody further elevated the immune responses by up-regulating the maturation of DCs as well as the ratios of CD8+ CTLs/Treg and CD4+ Teff/Treg. Therefore, such a multifunctional strategy exhibited great potential for inhibiting the growth of orthotopic and metastatic breast cancer. 关 键 词:CHECKPOINT BLOCKADE Immunotherapy IMMUNOGENIC cell death ANTI-METASTASIS Nanoparticle
相关文献

参考文献(55)

引证文献(8)

耦合文献(13)

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费